|
| Status |
Public on Dec 13, 2021 |
| Title |
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35029648 |
| |
| Submission date |
Jan 12, 2021 |
| Last update date |
Mar 14, 2022 |
| Contact name |
Maria Tsoumakidou |
| E-mail(s) |
tsoumakidou@fleming.gr
|
| Organization name |
B.S.R.C. "Alexander Fleming"
|
| Lab |
Tsoumakidou
|
| Street address |
34 Fleming Street
|
| City |
Vari |
| State/province |
Attica |
| ZIP/Postal code |
16672 |
| Country |
Greece |
| |
|
| Platforms (2) |
| GPL18635 |
Ion Torrent Proton (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (13)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE164653 |
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. [CAF] |
| GSE164659 |
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. [CD4 T cells] |
|
| Relations |
| BioProject |
PRJNA691506 |
Less...
More...